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Abstract
Given that fermented dairy products exhibit high bioactivities against cardiovas-
cular diseases (CVDs), the anti-thrombotic properties, fatty acid profiles and
sensory properties of cow, goat and ewe derived Greek yogurts have been assessed
and compared. The total lipids (TL), total polar lipids (TPL), total neutral lipids
(TNL) were obtained and the polar lipid fractions were further separated by thin
layer chromatography (TLC). These lipid samples (TL, TPL and TLC fractions)
were subsequently assessed for their biological activity against atherosclerosis
based on the in vitro inhibition of Platelet Activating Factor (PAF)-induced platelet
aggregation. The fatty acid compositions of all yogurts were analyzed by Gas
Chromatography with flame ionization detector (GC-FID). Goat yogurt lipids have
been found to exert more potent inhibitory activity (i.e. lower IC50 values in both
TL and TPL samples) in contrast to the corresponding fractions of cow and ewe
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yogurts. The observed sensory data indicates that ewe yogurt was the most
palatable of all three Greek yogurts.
Keywords: Food Science
1. Introduction
Despite the fact that milk and dairy products are considered fundamental
constituents of the Mediterranean diet and it is thus suggested that they are to be
consumed daily; dairy products have been the subject of controversy regarding their
impact on human health. According to the recommendations of the World Health
Organization (WHO), consumption of dairy products should be limited in order to
minimize the intake of cholesterol and saturated fatty acids (SFA) such as palmitic
and myristic acid, in order to reduce the incidences of cardiovascular disease risk
globally (World Health Organisation, 2002). On the other hand, several clinical
studies suggest that the consumption of milk and dairy products may exert a possible
protective effect against coronary heart disease, since they contain components such
as calcium, magnesium, potassium, vitamin D and certain amino acids (Chrysant and
Chrysant, 2013). Some constituents such as peptides, linoleic acid, conjugated
linoleic acid (CLA), antioxidants, lactic acid bacteria and probiotic bacteria present in
milk and dairy products have been shown to contribute to the functionality of dairy
products against chronic diseases (Rogelj, 2000). Dairy products also contain polar
lipids such as phosphatidylcholine (PC) and sphingomyelin (SM), which are mainly
located in the milk fat globule membrane. Evidence suggests that both PC and SM
possess strong anti-inflammatory activities and therefore the capacity to attenuate
cardiovascular risk (Liu et al., 2015).
Milk has been found to have moderate cardioprotective properties in comparison to
fermented dairy products, especially yogurt. The biologically active peptides
derived during bacterial fermentation of milk are thought to have anti-thrombotic
properties (Ivey et al., 2015). Moreover, during yogurt fermentation, the bacteria
Streptococcus thermophillus and Lactobacillus bulgaricus seem to enhance the
bioformation of lipids capable of inhibiting platelet activation induced by Platelet
Activating Factor (PAF) (Antonopoulou et al., 1996). PAF, (1-O-alkyl-2-acetyl-sn-
glycero-3-phosphocholine) is a strong phospholipid intermediary of inflammation
(Demopoulos et al., 1979) and it is regarded as a trigger molecule for the onset of
atherogenesis (Demopoulos et al., 2003). PAF is involved in the inflammatory
generation of plaque and the hindrance of blood vessels, which are the main causes of
coronary heart diseases (Demopoulos et al., 2003). Milk and dairy products contain
compounds that can inhibit PAF activity, acting as PAF- inhibitors. These dairy
components are of particular nutritional merit because they impede platelet
aggregation in arteries while at the same time they prevent atheromatosis develop-
ment (Antonopoulou et al., 1996; Poutzalis et al., 2016; Tsorotioti et al., 2014).
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Recent studies have demonstrated that dairy products may possess cardioprotective
and immunomodulatory bioactivities in vivo. In one such study, the cardiovascular
impact of Minas Frescal cheese consumption was assessed in hypertensive rats.
The consumption of this cheese resulted in the significant lowering of blood
pressure and an improved lipid profile in the rats (Lollo et al., 2015a). Furthermore,
another study examined probiotic fermented milk treated by dynamic high
pressure, which was fed to rats for 2 weeks. The fermented milk product was
effective in reducing the impact of exercise-induced immunosuppression (Lollo
et al., 2015b).
Greek yogurt is produced from three different kinds of milk namely cow, ewe and
goat milk. Generally Greek yogurt production does not standardize or homogenize
milk resulting in the formation of a crust on the yogurt’s surface (Serafeimidou
et al., 2012). Cow yogurt is consumed largely due to its low price and less
distinctive smell compared to those derived from other ruminant milk sources. The
aim of the current study was to evaluate the fatty acid contents, the in vitro anti-
thrombotic properties and the sensory characteristics of three different yogurts
produced from cow, ewe and goat milk respectively.
2. Materials and methods
2.1. Reagents and instruments
All reagents and solvents along with the silica gel G-60 used for Thin Layer
Chromatography (TLC) separation were supplied by Merck (Darmstadt, Germany).
Bovine serum albumin (BSA), PAF, the fatty acid methyl ester (FAME) standards
and the polar lipid standards used for TLC separation (mix standard of hen egg yolk)
were supplied by Sigma-Aldrich (St. Louis, MO, USA). Platelet aggregation was
measured using a Chrono-Log (Havertown, PA,USA) aggregometer (model 400-VS)
coupled to a Chrono-Log recorder (Havertown, PA, USA).
2.2. Yogurt samples
Three different types of Greek yogurt, i.e. cow, ewe and goat yogurt were
purchased from supermarkets in Athens, Greece. The lipid content of cow, ewe and
goat yogurt samples were 3.5%, 4.0% and 7.0%, respectively (i.e. g of lipid/100 g
food). All samples were sealed in clay pots, transferred to the laboratory and kept
at 4C prior to further analysis.
2.3. Isolation of total lipids (TL), total polar lipids (TPL) and
total neutral lipids (TNL)
Total lipids (TL) of all yogurt samples were extracted from 100 g of each sample
(cow, ewe and goat yogurt) according to the Bligh-Dyer method (Bligh and Dyer,
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1959) and separated into total polar lipids (TPL) and total neutral lipids (TNL) by
countercurrent distribution (Galanos and Kapoulas, 1962).
2.4. Fractionation of TPL by preparative Thin Layer
Chromatography (TLC)
The fractionation of TPL was carried out as described by Nasopoulou et al. (2007).
About 45 mg of goat and ewe yogurt TPL were applied to the TLC plates. All
isolated lipid fractions obtained were evaporated to dryness under nitrogen; the
lipids were weighed and re-dissolved in 1 mL chloroform/methanol 1:1 (v/v) and
stored at −20 °C until further analysis.
2.5. Biological assay on washed rabbit platelets
TL and TPL of the three types of yogurt (i.e. cow, ewe and goat yogurt) and TLC
polar lipid fractions of goat and ewe yogurt samples were tested for their in vitro
biological activity against 2.5 × 10−11 M PAF (final concentration in the cuvette)
towards washed rabbit platelets. Washed rabbit platelets were prepared as
described by Demopoulos et al. (1979). The EC50, namely the 50% maximal
effective concentration of aggregation, and IC50 the inhibitory concentration for
50% inhibition, values were calculated for each biologically active lipid fraction, as
described by Nasopoulou et al. (2007).
2.6. Gas chromatographic analysis
Fatty acid methyl esters (FAME) of 35 mg of TPL and 35 mg of TNL of all yogurt
samples were prepared and analyzed by GC-FID using the internal standard
method, as described by Nasopoulou et al. (2011). A five-point calibration curve
(given by the equation y = 0.00012x + 0.0167 with r = 0.99993) was prepared
using five solutions of heptadecanoic (17:0) acid methyl ester and heneicosanoic
(21:0) acid methyl ester in various ratios (Poutzalis et al., 2016). The ratio of the
area of the analyte peak to that of the internal standard represented the y value in
the above equation, and subsequently, the x value represents the analyte
concentration of the fatty acid in the unknown mixture. This equation was used
in order to quantify the analytes. The GC-FID analysis of FAMEs was carried out
as described by Nasopoulou et al. (2011).
2.7. Sensory evaluation of yogurt samples
The training of the panelists in order a) to identify and give scores for the attributes
taste, flavor, aftertaste and odour and b) to distinguish and give scores for the basic
senses of taste namely sweet, salty, bitter and sour was carried out as described by
Sioriki et al. (2015). The panel consisted of 10 assessors (5 females, 5 males), aged
24–45 years, recruited from the University of Athens. Four dairy products (milk;
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cheese; buttermilk and Greek feta cheese) were used for training the assessors to
different textures. During the seventh successive session, two samples of cow and
ewe yogurt, different from the samples used for the analysis in this study, were
used as a frame of reference in order to develop terminology based on the attribute
differences (Sioriki et al., 2015). The evaluation of taste, aftertaste and texture was
performed according to a list of fifteen attributes: five for taste (fatty, rich, sour,
delicious, whey), five for aftertaste (sweet, pleasant, goaty, intense, persistent), and
five for texture (creamy, smooth, velvety, grainy, fluid).
2.8. Statistical analysis
All experimental analyses were carried out in triplicate, and the obtained results
were expressed as mean value ± standard deviation (SD). One-way analysis of
variance (ANOVA) was employed in order to find the significant statistical
significant differences. When differences were identified at a significant level of
p < 0.05 then multiple comparisons of the means were conducted using the
Fisher’s least significant difference (LSD) test at p < 0.05. Statistical analysis of
the data was conducted using the statistical software package PASW 18 for
Windows (SPSS Inc., Chicago, 215 IL, USA). For the principal component
analysis (PCA), XLSTAT 18.06 (Addinsoft, Paris, France), was used.
3. Results
3.1. Lipid contents of cow, ewe and goat yogurt samples
The TL, TPL and TNL levels found in cow, ewe and goat yogurt are shown in
Table 1. Cow and goat yogurts have been found to have similar levels of TL and
TNL, whereas in the ewe’s yogurt sample, the levels of TL levels were found to be
statistically higher. The levels of TPL in cow and ewe yogurts were similar, but
goat yogurt contained statistically lower levels of TPL.
3.2. Fatty acid profile of TPL and TNL of cow, ewe and goat
yogurt samples
The TPL and TNL fatty acid profiles of cow, ewe and goat yogurt are presented in
Table 2 and Table 3, respectively. The levels of saturated fatty acids (SFA) were
found to be higher in both TPL and TNL of all yogurt samples followed by
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA).
Both the TPL and TNL of all yogurt samples contain the following fatty acids:
caproic (6:0), capric (10:0), lauric (12:0), myristic (14:0), palmitic (16:0), stearic
(18:0), oleic (18:1), linoleic (18:2) and a-linolenic (18:3) fatty acid. The most
abundant fatty acids in both the TPL and TNL yogurt lipid fractions were palmitic
(16:0), stearic (18:0) and oleic (18:1) fatty acids. The TPL fraction of ewe yogurt
was found to contain statistically higher levels (p < 0.05) of caproic (6:0), capric
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Table 1. Content of total lipids (TL), expressed in grams per 100 g yogurt (mean
± SD, n = 3), total polar lipids (TPL) and total neutral lipids (TNL), expressed as
percentages of TL in cow, goat and ewe yogurt samples.
Sample TL (g/100 g yogurt) TPL (% TL) TNL (% TL)
Cow 3.06 ± 0.92a 13.4 ± 2.01a 83.9 ± 5.56a
Goat 3.75 ± 0.90a 9.45 ± 1.78b 81.6 ± 5.02a
Ewe 6.76 ± 1.25b 13.2 ± 2.10a,b 77.6 ± 4.19a
a,bDifferent superscripts indicate significant differences among different yogurt samples within the same
lipid class (cow vs. ewe yogurt, goat vs. ewe yogurt and cow vs. goat yogurt, respectively; p < 0.05)
when means are compared using a Fisher’s LSD multiple comparison test.
Table 2. Fatty acid profile of total polar lipids (TPL) of each sample expressed in
milligrams per kilogram of each yogurt sample (mean ± SD, n = 3).
Fatty acids Cow yogurt Goat yogurt Ewe yogurt
6:0 22.1 ± 1.99a 12.4 ± 0.22b 54.7 ± 5.30c
8:0 ND 4.34 ± 0.28a 5.85 ± 0.27b
10:0 3.11 ± 0.16a 32.2 ± 1.20b 56.2 ± 4.38c
12:0 3.04 ± 0.15a 14.1 ± 0.52b 40.9 ± 1.16c
14:0 16.3 ± 0.32a 39.4 ± 0.82b 126 ± 4.28c
15:0 ND 1.00 ± 0.12a 3.55 ± 0.01b
16:0 59.3 ± 0.25a 142 ± 1.29b 293 ± 3.12c
16:1 (ω-7) 1.05 ± 0.05a 2.54 ± 0.21b ND
18:0 24.9 ± 0.01a 69.2 ± 0.59b 512 ± 9.25c
18:1 (cis) (ω-9) 52.6 ± 0.28a 173 ± 3.61b 243 ± 1.89c
18:2 (cis) (ω-6) 12.5 ± 0.03a 32.5 ± 0.15b 38.8 ± 0.01c
18:3 (cis) (ω-3) ND 5.21 ± 0.04a 8.90 ± 0.03b
20:0 ND 1.67 ± 0.16a 4.23 ± 1.10b
20:1 (ω-9) ND 0.29 ± 0.01a 1.52 ± 0.67b
20:4 ND 0.83 ± 0.06 ND
24:0 ND 0.83 ± 0.11 ND
SFA 129 ± 0.13a 317 ± 0.09b 1096 ± 0.03c
MUFA 53.7 ± 0.05a 176 ± 0.09b 245 ± 0.05c
PUFA 12.5 ± 0.05a 38.5 ± 0.07b 47.7 ± 0.04c
a,b,cDifferent superscripts indicate significant differences among different yogurt samples within the
same row (p < 0.05) when means are compared using a Fisher’s LSD multiple comparison test. SFA:
saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; ND: non
detectable.
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(10:0), lauric (12:0), myristic (14:0), palmitic (16:0), stearic (18:0), oleic (18:1)
and linoleic (18:2) fatty acids than the TPL fractions of goat and cow yogurts
(Table 2). The TNL fraction of goat yogurt was found to exhibit statistically higher
levels (p < 0.05) of caprylic acid (C8:0), capric (10:0), lauric (12:0), myristic
(14:0), palmitic (16:0), oleic (18:1), linoleic (18:2) and α-linolenic (18:3) fatty
acids in contrast to the TNL fractions of ewe and cow yogurts (Table 3). The rather
low levels of fatty acids in the TNL and TPL fractions are in concurrence with
similar work on the TPL and TNL of goat dairy products (Poutzalis et al., 2016).
3.3. In vitro anti-thrombotic activity of TL, TPL and TLC polar
lipid fractions
The TL, TPL and TLC polar lipid fractions of all yogurt samples were assessed
for their ability to induce washed rabbit platelet aggregation (EC50) or inhibit the
PAF-induced washed platelet aggregation (IC50). The corresponding results for
Table 3. Fatty acid profile of total neutral lipids (TNL) of each sample expressed
in milligrams per kilogram of each yogurt sample (mean ± SD, n = 3).
Fatty acids Cow yogurt Goat yogurt Ewe yogurt
6:0 182 ± 1.99a 211 ± 6.20b 340 ± 2.01c
8:0 31.8 ± 3.17a 118 ± 2.77b 9.46 ± 2.33c
10:0 200 ± 0.24a 748 ± 7.21b 198 ± 4.33c
12:0 194 ± 7.48a 294 ± 0.01b 138 ± 2.29c
14:0 653 ± 6.56a 913 ± 4.29b 457 ± 4.77c
14:1 (ω-5) 31.3 ± 1.03 ND ND
15:0 62.4 ± 0.86a 35.0 ± 0.13b 3.14 ± 0.86c
16:0 1959 ± 5.23a 3009 ± 2.64b 1422 ± 9.59c
16:1 (ω-7) 85.6 ± 1.05 ND ND
17:1 (ω-7) 7.96 ± 0.74 ND ND
18:0 665 ± 4.74a 1917 ± 10.9b 2575 ± 4.72c
18:1 (cis) (ω-9) 1910 ± 0.27a 2399 ± 0.12b 1288 ± 4.52c
18:2 (cis) (ω-6) 207 ± 0.13a 286 ± 0.71b 158 ± 0.08c
18:3 (cis) (ω-3) 10.7 ± 0.07a 62.3 ± 0.18b 13.8 ± 9.75c
20:0 ND ND 14.5 ± 0.12
SFA 3947 ± 0.02a 7245± 0.07b 5157 ± 0.08c
MUFA 2035 ± 0.11a 2399 ± 0.03b 1288 ± 0.06c
PUFA 218 ± 0.04a 348 ± 0.03b 172 ± 0.03c
a,b,cDifferent superscripts indicate significant differences among different yogurt samples within the
same row (p < 0.05) when means are compared using a Fisher’s LSD multiple comparison test. SFA:
saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; ND: non
detectable.
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biological activity are expressed in micrograms (μg) for the TL and TPL fractions
of all yogurt samples and are presented in Fig. 1.
According to Fig. 1, both the TL and TPL fractions of all three yogurt samples
have been found to exert inhibitory activity, thus, it could be suggested that these
fractions contain lipids that act as PAF inhibitors. The IC50 values for the TL and
TPL goat yogurt samples (33.0 μg and 15.4 μg, respectively), were found to be
significantly lower (p < 0.05) compared to the values for ewe yogurt (43.1 μg and
27.2 μg, respectively) and cow yogurt (45.4 μg and 40.8 μg, respectively) (Fig. 1).
At this point, it should be emphasized that the lower the IC50 value, the stronger the
anti-thrombotic potency of the lipid fraction, since less amount of lipid is required
to exert 50% inhibition of the PAF-induced washed platelet aggregation. Finally, it
should also be stated that the TPL of all three yogurt samples have been found to
show stronger inhibitory activity than the TL, within the same yogurt sample
(Fig. 1); neither the TL nor the TPL of all samples showed any aggregation.
According to Fig. 1, the TPL of goat and ewe yogurt have been found to exhibit the
strongest in vitro anti-thrombotic activity; thus these lipid fractions were selected
for further separation by preparative TLC, as shown in Fig. 2a and b, respectively.
The biological activities of the TLC polar lipid fractions derived from goat and ewe
yogurts, expressed in micrograms (μg), are shown in Fig. 3a and b, respectively.
According to Fig. 2a and b, seven bands of polar lipid fractions have been found in
both yogurt samples. These results correspond with previously published research
on the lipid fractions obtained in goat cheese (Poutzalis et al., 2016).
All TLC polar lipid fractions of goat and ewe yogurt were found to exhibit
inhibitory activity against the actions of PAF (IC50 value), while only band 2 of the
[(Fig._1)TD$FIG]
Fig. 1. In vitro biological activities of total lipids (TL) and total polar lipids (TPL) of cow, ewe and
goat yogurts towards washed rabbit platelet aggregation, expressed in micrograms of TL and TPL.
Washed rabb i t p l a t e l e t concen t r a t i on was app rox ima t e ly 500 ,000 p l a t e l e t s
μL −1. The final concentration of PAF in the cuvette was 2.5 × 10−11 M. The experimental analyses
were carried out in triplicate (n = 3).
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[(Fig._2)TD$FIG]
Fig. 2. Typical profile of total polar lipid (TPL) separation on preparative thin-layer chromatography
(TLC). a) goat yogurt sample, b) ewe yogurt sample. In the photo, the seven bands obtained are shown
on the right whereas on the left, the corresponding elution front of standard compounds is given. L-PC:
lyso-phosphatidylcholine, SM: sphingomyelin, PC: phosphatidylcholine, L-PE: lyso-phosphatidyletha-
nolamine, PE: phosphatidylethanolamine, CL: cardiolipin. The preparative plates TLC were stained
with iodine vapours.
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TLC polar lipid fractions exhibited aggregatory activity (EC50 value) (Fig. 3a and
b). The TLC polar lipid fraction 2 has been found to have a similar Rf value
corresponding to sphingomyelin (SM). The TLC polar lipid fractions 3 and 7 of the
goat yogurt samples exert a greater in vitro anti-thrombotic activity in comparison
to the respective TLC polar lipid fractions of the ewe yogurt sample (28.4 μg as
opposed to 122 μg for fraction 3 and 46.8 μg as opposed to 85.2 μg for fraction 7
(Fig. 3a and b). Fractions 3 and 7 correspond to the Rf values of phosphatidylcho-
line (PC) and cardiolipin (CL), respectively.
[(Fig._3)TD$FIG]
Fig. 3. In vitro biological activity of preparative thin-layer chromatography (TLC) polar lipid fractions
of a) goat yogurt sample and b) ewe yogurt sample, towards washed rabbit platelet aggregation,
expressed in micrograms. Washed rabbit platelet concentration was approximately 500,000 platelets μL
−1. The final concentration of PAF in the cuvette was 2.5 × 10−11 M. The experimental analyses were
carried out in triplicate (n = 3).
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By comparing the biological activities of the TLC polar lipid fractions of both
yogurt samples, it could be said that the TLC polar lipid fractions 3, 4, 5, 6 and 7 of
goat yogurt sample have been found to exert statistically lower IC50 values
(p < 0.05). Therefore, the goat TLC polar lipid fractions possess stronger anti-
thrombotic activity in comparison to the activity of the ewe yogurt TLC polar lipid
fraction (Fig. 3a and b). Conversely, the TLC polar lipid fractions 1 and 2 of the
goat yogurt sample have shown statistically higher IC50 values (p < 0.05)
compared to the ewe yogurt sample (Fig. 3a and b). The TLC lipid fraction 3 of
both yogurt samples, which has an Rf value corresponding to phosphatidylcholine
(PC), also exhibited potent in vitro anti-thrombotic activity.
3.4. Sensory analysis
The panelists scored the three yogurt samples using values between zero (0, least
liked) and ten (10, most liked) for attributes describing the taste, aftertaste and
texture properties. The scores of each yogurt sample (cow, ewe or goat yogurt
samples) for each attribute used are given in the form of spider-web plots (Fig. 4).
The sensory data was also subjected to principal component analysis in order to
detect if there was a pattern in the sensory data (Matera et al., 2014).
The assessors indicated statistically significant organoleptic differences among
cow, ewe and goat yogurt. According to Fig. 4, the ewe yogurt sample has been
found to rate significantly higher for the taste attributes of “fatty”, “rich”,
“delicious”, and “whey” and for the texture attribute “‘grainy”’. On the other hand,
the goat yogurt sample has been found to rate significantly higher for the attribute
of “sour” for taste, the attributes of “persistent”, “intense”, and “goaty” for the
aftertaste and the attributes of “velvety”, “smooth” and “fluid” for the texture
(Fig. 4). The cow yogurt samples have been found to rate significantly higher only
for the aftertaste attribute of “sweet” (Fig. 4). As it is observed from the PCA
(Fig. 5), the first two factors accounted for 25.25% and 19.09% of the variance
respectively. Factor one separated most of the samples B (goat yogurt) from
samples A and C (ewe and cow yogurts respectively). The goat yogurt was
characterised as goaty, rich, smooth, intense and persistent. However, in the case of
F2 the separation was not clear. Despite the fact that only 44.34% of the variance
was described using the first two factors, we still gain a useful insight into the
positioning of the three yogurts in relation to their sensory characteristics.
4. Discussion
Dairy products have been linked with the increased risk of CVDs, due to their high
concentration in SFA and cholesterol (Mann, 2002). However, recent data on the
levels of bioactive fatty acids (e.g. short-chain fatty acids and CLA) and other
minor components (e.g. phospholipids and sphingolipids) indicate that dairy
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[(Fig._4)TD$FIG]
Fig. 4. Comparison of sensory profiles of cow, ewe and goat yogurt samples. The scores for a) taste b)
aftertaste and c) texture attributes are given as spider-web plots.
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products may have a positive important impact on cardiovascular and metabolic
risk factors (Castro-Gómez et al., 2014).
In the current study, it was demonstrated that the TL and TPL fractions of all
yogurt samples tested (cow, ewe and goat yogurts) contain PAF inhibitors (Fig. 1),
which is in accordance with the literature (Antonopoulou et al., 1996; Poutzalis
et al., 2016). The TL and TPL of the goat yogurt samples exhibited the most potent
biological activity against PAF (Fig. 1), suggesting that goat yogurt contains more
potent PAF inhibitors than the cow or ewe yogurts and thus stronger in vitro anti-
thrombotic properties. The in vitro anti-thrombotic properties of these yogurts
could be attributed to the fact that during yogurt fermentation, bacteria such as
Streptococcus thermophilus and Lactobacillus bulgaricus seem to augment the
biosynthesis of lipids capable of inhibiting PAF activity (Antonopoulou et al.,
1996; Antonopoulou et al., 2006).
The TLC polar lipid fractions 3 and 7 of both goat and ewe yogurts exhibited
potent inhibitory activity against PAF-induced platelet aggregation (Fig. 3) and
were found to have similar Rf values to those of PC and CL. The concentrations of
PC and CL in goat and ewe milk are considerably high (Castro-Gómez et al.,
2014). It could therefore be suggested that the strong in vitro anti-thrombotic
activities found in goat and ewe yogurts could be due to biologically active lipids
that are derivatives of PC and CL (Zabetakis, 2013; Nasopoulou et al., 2014).
The TLC polar lipid fraction 2 of both yogurt samples (goat and ewes), were found
to contain lipid micro constituents inducing platelet aggregation (Fig. 3), thus
[(Fig._5)TD$FIG]
Fig. 5. Principal component analysis (PCA) of the three yogurt samples (A: ewe yogurt, B: goat yogurt,
C: cow yogurt).
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acting as PAF agonists. The presence of such PAF agonists (i.e. lipids with
aggregatory activity) is beneficial because PAF agonists have been found to exhibit
stronger in vivo antiatherogenic activity than PAF-inhibitors (Nasopoulou et al.,
2010; Tsantila et al., 2007). This can be explained on the basis that these PAF
agonists have a higher affinity than PAF to the PAF G-protein coupled receptors,
hence they compete with PAF for its receptors; this biochemical competition
results in antiatherogenic activity (Nasopoulou et al., 2010).
The results of the present study indicate that the lipid fractions (TPL or TLC polar
lipid fractions) of all yogurt samples exhibited either aggregatory or inhibitory
actions, suggesting that these lipid fractions are biologically active against PAF
activity and consequently against thrombosis.
The results of the extracted TL of all yogurt samples reflected their reported fat
concentration. The ewe’s yogurt sample (7% fat) contained the highest TL levels.
The TNL of all three yogurt samples were found to be the dominant lipid class
whereas the TPL were present in lower levels (Table 1).
SFAs were found to be higher in both the TPL and TNL of all yogurt samples
followed by MUFAs and PUFAs, while the predominant fatty acids identified were
palmitic (C16:0), oleic (C18:1), and stearic (C18:0) fatty acids (Table 2a and b),
which is in agreement with the literature (Poutzalis et al., 2016; Serafeimidou et al.,
2012). A number of metabolically valuable short and medium carbon chain FAs
that are associated with the characteristic yogurt flavour and taste were identified.
These include caproic (C6:0), caprylic (C8:0), capric (C10:0) and lauric (C12:0)
fatty acids. The presence of these FAs was significantly higher in goat and ewe
yogurts as opposed to cow yogurt (Table 2a and b). The differences in fatty acid
levels among these yogurt samples is species specific and can vary due to the
different types of milk; the breed, age, stage of lactation and the nutrition of the
animal (Serafeimidou et al., 2012; Michaelidou 2008; Park et al., 2007).
The sensory evaluation of the yogurt samples demonstrated that the goat and ewe
yogurts have been found to rate significantly higher for specific taste, aftertaste and
texture attributes (Fig. 4). Such organoleptic variations may be related to the
observed differences in lipid content and fatty acid profile of the yogurt samples.
The evaluation also identified that the ewe yogurt sample was the most palatable.
5. Conclusions
The in vitro anti-thrombotic activities, the fatty acid levels and the organoleptic
properties of traditional Greek yogurts made using three different types of milk,
were determined. The results highlight the biological properties of Greek yogurt
lipids against thrombosis, suggesting a potential cardio-protective capacity for
these yogurts. The fatty acid contents along with the organoleptic properties varied
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according to the type of milk used in the production of these yogurts. Our
aggregometric data suggests that goat and ewe yogurt have stronger anti-
thrombotic properties as opposed to cow yogurt. It is proposed that the activities
evident in goat and ewe yogurts could be linked to lipids that are PC derivatives
since they exhibit similar Rf values to PC. Further mechanistic studies are required
in order to elucidate the structure of these potent anti-thrombotic yogurt derived
lipids.
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